Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC8 | Q9BY41 | 10/20 | 1.00 |
| ▸ | HDAC6 | Q9UBN7 | 7/20 | 1.00 |
| ▸ | HDAC7 | Q8WUI4 | 4/20 | 1.00 |
| ▸ | HDAC9 | Q9UKV0 | 4/20 | 1.00 |
| ▸ | HDAC5 | Q9UQL6 | 4/20 | 1.00 |
| ▸ | CA1 | P00915 | 2/20 | 0.61 |
| ▸ | CA2 | P00918 | 2/20 | 0.61 |
| ▸ | HDAC1 | Q13547 | 8/20 | 0.52 |
| ▸ | HDAC2 | Q92769 | 7/20 | 0.52 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.52 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.52 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.52 |
| ▸ | HTR2A | P28223 | 1/20 | 0.52 |
| ▸ | HTR2C | P28335 | 1/20 | 0.52 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.52 |
| ▸ | HRH1 | P35367 | 1/20 | 0.52 |
| ▸ | DRD3 | P35462 | 1/20 | 0.52 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | HDAC3 | O15379 | 7/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18520585 | 0.91 | HDAC8 (0.83) | HDAC8HDAC6HDAC7HDAC9HDAC5 | |
| SCHEMBL28473668 | 0.85 | CA2 (0.83) | HDAC8HDAC6HDAC7HDAC9HDAC5 | |
| SCHEMBL19910585 | 0.81 | CA2 (0.70) | HDAC8HDAC6HDAC7HDAC9HDAC5 | |
| SCHEMBL24932772 | 0.81 | CA2 (0.70) | HDAC8HDAC6HDAC7HDAC9HDAC5 | |
| SCHEMBL7750482 | 0.81 | CA2 (0.70) | HDAC8HDAC6HDAC7HDAC9HDAC5 | |
| SCHEMBL3367550 | 0.79 | HDAC7 (0.65) | HDAC8HDAC6HDAC7HDAC9HDAC5 | |
| SCHEMBL12864235 | 0.78 | — | — | |
| SCHEMBL3049838 | 0.77 | — | — | |
| SCHEMBL28686448 | 0.77 | HDAC8 (0.62) | HDAC8HDAC6HDAC7HDAC9HDAC5 | |
| SCHEMBL28987848 | 0.77 | CA1 (0.63) | HDAC8HDAC6HDAC7HDAC9HDAC5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024072204-A1 | PROCESS FOR PRODUCING NANOMETRE-SIZED METALLIC SOAPS | SILVER TECH DE MEXICO SA DE CV (MX) | 2024-04-04 | — | — | WO | claimed |
| EP-4694679-A2 | DEGRADABLE FISHING LINES AND NETS | Enviro Cast, LLC (US) | 2026-02-18 | — | — | EP | disclosed |
| WO-2025075493-A1 | COMPOSITION FOR SWEETENING BEVERAGES, FOOD AND DESSERTS, IN THE FORM OF A POWDER FOR MAKING FLAVOURED SYRUPS | BARRAGAN ESPINOSA GEORGINA (MX) | 2025-04-10 | — | — | WO | disclosed |
| EP-4532552-A1 | METHODS AND COMPOSITIONS FOR PREVENTING OR DELAYING TYPE 1 DIABETES | Provention Bio, Inc. (US) | 2025-04-09 | — | — | EP | disclosed |
| WO-2025072291-A1 | ZEIN COATED OR IMPREGNATED PAPER STRAWS AND RELATED TUBULAR ARTICLES | KALYKOS LLC (US) | 2025-04-03 | — | — | WO | disclosed |
| WO-2025037130-A1 | TIO2-BASED MATERIAL (TIO2-NP), AND METHOD FOR THE SYNTHESIS THEREOF, HAVING A MULTIFUNCTIONAL AND VERSATILE PROPERTY FOR THE SIMULTANEOUS AND ONE-STEP PHOTO-OXIDATION AND ADSORPTION OF DIFFERENT POLLUTANTS, SUCH AS ARSENIC, ALUMINIUM, BARIUM, BORON, IRON, LITHIUM, MANGANESE, MOLYBDENUM, STRONTIUM, ANTIMONY, SILICON, ZINC AND CALCIUM, FROM WATER AND EFFLUENTS, AND THE RECOVERY, REUSE AND REGENERATION THEREOF | UNIVERSIDAD DE CHILE (CL) | 2025-02-20 | — | — | WO | disclosed |
| US-12162802-B2 | Glasses having improved ion exchangeability and thermal expansion | SCHOTT AG (DE) | 2024-12-10 | — | — | US | disclosed |
| US-20240398986-A1 | An oncolytic virus vector coding for interleukin-7 (IL-7) polypeptide | TILT BIOTHERAPEUTICS OY (FI) | 2024-12-05 | — | — | US | disclosed |
| CN-115035542-B | System and method for matching a test frame sequence to a reference frame sequence | 林德拉股份有限公司 | 2024-11-05 | — | — | CN | disclosed |
| US-20240362846-A1 | SYSTEM AND METHOD FOR MATCHING A TEST FRAME SEQUENCE WITH A REFERENCE FRAME SEQUENCE | LINDERA GMBH (DE) | 2024-10-31 | — | — | US | disclosed |
| CN-110282874-B | Glass with improved ion exchange and thermal expansion | 肖特股份有限公司 | 2022-03-25 | — | — | CN | disclosed |
| US-11260130-B2 | Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using a GSK3 inhibitor: IV | Frequency Therapeutics, Inc. (US) | 2022-03-01 | — | — | US | disclosed |
| EP-3952854-A1 | COMBINATION OF CHIR99021 AND VALPROIC ACID FOR TREATING HEARING LOSS | Frequency Therapeutics, Inc. (US) | 2022-02-16 | — | — | EP | disclosed |
| US-10391070-B2 | Compositions and methods for treating neurological diseases or injury | MUSC FOUNDATION FOR RESEARCH DEVELOPMENT (US) | 2019-08-27 | — | — | US | disclosed |
| US-20180185306-A1 | COMPOSITIONS AND METHODS FOR TREATING NEUROLOGICAL DISEASES OR INJURY | MUSC FOUNDATION FOR RESEARCH DEVELOPMENT (US) | 2018-07-05 | — | — | US | disclosed |
| US-9861596-B2 | Compositions and methods for treating neurological diseases or injury | MUSC FOUNDATION FOR RESEARCH DEVELOPMENT (US) | 2018-01-09 | — | — | US | disclosed |
| US-20150320702-A1 | COMPOSITIONS AND METHODS FOR TREATING NEUROLOGICAL DISEASES OR INJURY | MEDICAL UNIVERSITY OF SOUTH CAROLINA | 2015-11-12 | — | — | US | disclosed |
| WO-2014074976-A1 | COMPOSITIONS AND METHODS FOR TREATING NEUROLOGICAL DISEASES OR INJURY | MUSC FOUNDATION FOR RESEARCH DEVELOPMENT (US) | 2014-05-15 | — | — | WO | disclosed |
| EP-2698156-A1 | Phenylbutyric acid for chemoprevention | Lunamed AG (CH) | 2014-02-19 | — | — | EP | disclosed |
| EP-2125023-B1 | SOLUBLE FORMS OF INCLUSION COMPLEXES OF HISTONE DEACETYLASE INHIBITORS AND CYCLODEXTRINS, THEIR PREPARATION PROCESSES AND USES IN THE PHARMACEUTICAL FIELD | UNIV ROMA (IT) | 2013-10-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10391070-B2 | Compositions and methods for treating neurological diseases or injury | PROC, GLS, NLN | HDAC8 2263/4885HDAC6 1759/4885HDAC7 2066/4885 |
| US-20150320702-A1 | COMPOSITIONS AND METHODS FOR TREATING NEUROLOGICAL DISEASES OR INJURY | PROC, GLS, NLN | HDAC8 2263/4885HDAC6 1759/4885HDAC7 2066/4885 |
| US-20180185306-A1 | COMPOSITIONS AND METHODS FOR TREATING NEUROLOGICAL DISEASES OR INJURY | PROC, GLS, NLN | HDAC8 2263/4885HDAC6 1759/4885HDAC7 2066/4885 |
| US-11260130-B2 | Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using a GSK3 inhibitor: IV | GSK3B, GSK3A, GSKIP | HDAC8 1102/4885HDAC6 1765/4885HDAC7 718/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.